Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis

Project: Research project

Project Details

StatusFinished
Effective start/end date2/25/05 → 5/25/05

Funding

  • Parexel (CZOL446H2315 // CZOL446H2315)
  • Novartis Pharmaceuticals Corporation (CZOL446H2315 // CZOL446H2315)